Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 7/2017

01-07-2017 | Original Article

Serious fungal infections in Portugal

Authors: R. Sabino, C. Verissímo, J. Brandão, C. Martins, D. Alves, C. Pais, D. W. Denning

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 7/2017

Login to get access

Abstract

There is a lack of knowledge on the epidemiology of fungal infections worldwide because there are no reporting obligations. The aim of this study was to estimate the burden of fungal disease in Portugal as part of a global fungal burden project. Most published epidemiology papers reporting fungal infection rates from Portugal were identified. Where no data existed, specific populations at risk and fungal infection frequencies in those populations were used in order to estimate national incidence or prevalence, depending on the condition. An estimated 1,510,391 persons develop a skin or nail fungal infection each year. The second most common fungal infection in Portugal is recurrent vulvovaginal candidiasis, with an estimated 150,700 women (15–50 years of age) suffering from it every year. In human immunodeficiency virus (HIV)-infected people, oral or oesophageal candidiasis rates were estimated to be 19.5 and 16.8/100,000, respectively. Candidaemia affects 2.19/100,000 patients, in a total of 231 cases nationally. Invasive aspergillosis is less common than in other countries as chronic obstructive pulmonary disease (COPD) is uncommon in Portugal, a total of 240 cases annually. The estimated prevalence of chronic pulmonary aspergillosis after tuberculosis (TB) is 194 cases, whereas its prevalence for all underlying pulmonary conditions was 776 patients. Asthma is common (10% in adults) and we estimate 16,614 and 12,600 people with severe asthma with fungal sensitisation and allergic bronchopulmonary aspergillosis, respectively. Sixty-five patients develop Pneumocystis pneumonia in acquired immune deficiency syndrome (AIDS) and 13 develop cryptococcosis. Overall, we estimate a total number of 1,695,514 fungal infections starting each year in Portugal.
Literature
5.
go back to reference Rodriguez-Tudela JL, Alastruey-Izquierdo A, Gago S, Cuenca-Estrella M, León C, Miro JM, Nuñez Boluda A, Ruiz Camps I, Sole A, Denning DW; University of Manchester in association with the LIFE program (2015) Burden of serious fungal infections in Spain. Clin Microbiol Infect 21:183–189. doi:10.1016/j.cmi.2014.07.013 CrossRefPubMed Rodriguez-Tudela JL, Alastruey-Izquierdo A, Gago S, Cuenca-Estrella M, León C, Miro JM, Nuñez Boluda A, Ruiz Camps I, Sole A, Denning DW; University of Manchester in association with the LIFE program (2015) Burden of serious fungal infections in Spain. Clin Microbiol Infect 21:183–189. doi:10.​1016/​j.​cmi.​2014.​07.​013 CrossRefPubMed
8.
go back to reference República PortuguesaDireção-Geral da Saúde. Histórico de Destaques.Apresentação Pública do Relatório «Portugal em números 2015 – Infeção VIH, SIDA e Tuberculose». Available online at: http://www.dgs.pt/?cr=29118. Accessed 25 May 2016 República PortuguesaDireção-Geral da Saúde. Histórico de Destaques.Apresentação Pública do Relatório «Portugal em números 2015 – Infeção VIH, SIDA e Tuberculose». Available online at: http://​www.​dgs.​pt/​?​cr=​29118. Accessed 25 May 2016
14.
17.
go back to reference Bárbara C, Rodrigues F, Dias H, Cardoso J, Almeida J, Matos MJ, Simão P, Santos M, Ferreira JR, Gaspar M, Gnatiuc L, Burney P (2013) Chronic obstructive pulmonary disease prevalence in Lisbon, Portugal: the burden of obstructive lung disease study. Rev Port Pneumol 19:96–105. doi:10.1016/j.rppneu.2012.11.004 CrossRefPubMed Bárbara C, Rodrigues F, Dias H, Cardoso J, Almeida J, Matos MJ, Simão P, Santos M, Ferreira JR, Gaspar M, Gnatiuc L, Burney P (2013) Chronic obstructive pulmonary disease prevalence in Lisbon, Portugal: the burden of obstructive lung disease study. Rev Port Pneumol 19:96–105. doi:10.​1016/​j.​rppneu.​2012.​11.​004 CrossRefPubMed
20.
go back to reference Veríssimo C, Brandão J, Simões HL, Sabino R (2015) Dermatophyte infections in the Lisbon and Tagus valley. Mycoses 58:220–221, AbstractCrossRef Veríssimo C, Brandão J, Simões HL, Sabino R (2015) Dermatophyte infections in the Lisbon and Tagus valley. Mycoses 58:220–221, AbstractCrossRef
21.
go back to reference Valdigem GL, Pereira T, Macedo C, Duarte ML, Oliveira P, Ludovico P, Sousa-Basto A, Leão C, Rodrigues F (2006) A twenty-year survey of dermatophytoses in Braga, Portugal. Int J Dermatol 45:822–827CrossRefPubMed Valdigem GL, Pereira T, Macedo C, Duarte ML, Oliveira P, Ludovico P, Sousa-Basto A, Leão C, Rodrigues F (2006) A twenty-year survey of dermatophytoses in Braga, Portugal. Int J Dermatol 45:822–827CrossRefPubMed
23.
go back to reference Organisation for Economic Co-operation and Development (OECD) (2015) OECD reviews of health care quality: Portugal 2015: raising standards. OECD Publishing, Paris Organisation for Economic Co-operation and Development (OECD) (2015) OECD reviews of health care quality: Portugal 2015: raising standards. OECD Publishing, Paris
28.
go back to reference Denning DW, Pleuvry A, Cole DC (2013) Global burden of allergic bronchopulmonary aspergillosis with asthma and its complication chronic pulmonary aspergillosis in adults. Med Mycol 51:361–370CrossRefPubMed Denning DW, Pleuvry A, Cole DC (2013) Global burden of allergic bronchopulmonary aspergillosis with asthma and its complication chronic pulmonary aspergillosis in adults. Med Mycol 51:361–370CrossRefPubMed
29.
go back to reference Denning DW, O’Driscoll BR, Hogaboam CM, Bowyer P, Niven RM (2006) The link between fungi and severe asthma: a summary of the evidence. Eur Respir J 27:615–626CrossRefPubMed Denning DW, O’Driscoll BR, Hogaboam CM, Bowyer P, Niven RM (2006) The link between fungi and severe asthma: a summary of the evidence. Eur Respir J 27:615–626CrossRefPubMed
30.
go back to reference Denning DW, Cadranel J, Beigelman-Aubry C, Ader F, Chakrabarti A, Blot S, Ullmann AJ, Dimopoulos G, Lange C; European Society for Clinical Microbiology and Infectious Diseases and European Respiratory Society (2016) Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management. Eur Respir J 47:45–68. doi:10.1183/13993003.00583-2015 CrossRefPubMed Denning DW, Cadranel J, Beigelman-Aubry C, Ader F, Chakrabarti A, Blot S, Ullmann AJ, Dimopoulos G, Lange C; European Society for Clinical Microbiology and Infectious Diseases and European Respiratory Society (2016) Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management. Eur Respir J 47:45–68. doi:10.​1183/​13993003.​00583-2015 CrossRefPubMed
31.
go back to reference Yan X, Li M, Jiang M, Zou L-Q, Luo F, Jiang Y (2009) Clinical characteristics of 45 patients with invasive pulmonary aspergillosis: retrospective analysis of 1711 lung cancer cases. Cancer 115:5018–5025. doi:10.1002/cncr.24559 CrossRefPubMed Yan X, Li M, Jiang M, Zou L-Q, Luo F, Jiang Y (2009) Clinical characteristics of 45 patients with invasive pulmonary aspergillosis: retrospective analysis of 1711 lung cancer cases. Cancer 115:5018–5025. doi:10.​1002/​cncr.​24559 CrossRefPubMed
33.
go back to reference Herbrecht R, Bories P, Moulin JC, Ledoux MP, Letscher-Bru V (2012) Risk stratification for invasive aspergillosis in immunocompromised patients. Ann N Y Acad Sci 1272:23–30CrossRefPubMed Herbrecht R, Bories P, Moulin JC, Ledoux MP, Letscher-Bru V (2012) Risk stratification for invasive aspergillosis in immunocompromised patients. Ann N Y Acad Sci 1272:23–30CrossRefPubMed
34.
go back to reference Faria-Ramos I, Neves-Maia J, Ricardo E, Santos-Antunes J, Silva AT, Costa-de-Oliveira S, Cantón E, Rodrigues AG, Pina-Vaz C (2014) Species distribution and in vitro antifungal susceptibility profiles of yeast isolates from invasive infections during a Portuguese multicenter survey. Eur J Clin Microbiol Infect Dis 33:2241–2247. doi:10.1007/s10096-014-2194-8 CrossRefPubMed Faria-Ramos I, Neves-Maia J, Ricardo E, Santos-Antunes J, Silva AT, Costa-de-Oliveira S, Cantón E, Rodrigues AG, Pina-Vaz C (2014) Species distribution and in vitro antifungal susceptibility profiles of yeast isolates from invasive infections during a Portuguese multicenter survey. Eur J Clin Microbiol Infect Dis 33:2241–2247. doi:10.​1007/​s10096-014-2194-8 CrossRefPubMed
35.
go back to reference Nguyen MH, Wissel MC, Shields RK, Salomoni MA, Hao B, Press EG, Shields RM, Cheng S, Mitsani D, Vadnerkar A, Silveira FP, Kleiboeker SB, Clancy CJ (2012) Performance of Candida real-time polymerase chain reaction, β-D-glucan assay, and blood cultures in the diagnosis of invasive candidiasis. Clin Infect Dis 54:1240–1248. doi:10.1093/cid/cis200 CrossRefPubMed Nguyen MH, Wissel MC, Shields RK, Salomoni MA, Hao B, Press EG, Shields RM, Cheng S, Mitsani D, Vadnerkar A, Silveira FP, Kleiboeker SB, Clancy CJ (2012) Performance of Candida real-time polymerase chain reaction, β-D-glucan assay, and blood cultures in the diagnosis of invasive candidiasis. Clin Infect Dis 54:1240–1248. doi:10.​1093/​cid/​cis200 CrossRefPubMed
36.
go back to reference Buchacz K, Baker RK, Palella FJ Jr, Chmiel JS, Lichtenstein KA, Novak RM, Wood KC, Brooks JT; HOPS Investigators (2010) AIDS-defining opportunistic illnesses in US patients, 1994–2007: a cohort study. AIDS 24:1549–1559CrossRefPubMed Buchacz K, Baker RK, Palella FJ Jr, Chmiel JS, Lichtenstein KA, Novak RM, Wood KC, Brooks JT; HOPS Investigators (2010) AIDS-defining opportunistic illnesses in US patients, 1994–2007: a cohort study. AIDS 24:1549–1559CrossRefPubMed
37.
go back to reference Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M et al (2012) Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380:2163–2196CrossRefPubMed Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M et al (2012) Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380:2163–2196CrossRefPubMed
38.
go back to reference Torres-Narbona M, Guinea J, Martínez-Alarcón J, Muñoz P, Gadea I, Bouza E; MYCOMED Zygomycosis Study Group (2007) Impact of zygomycosis on microbiology workload: a survey study in Spain. J Clin Microbiol 45:2051–2053CrossRefPubMedPubMedCentral Torres-Narbona M, Guinea J, Martínez-Alarcón J, Muñoz P, Gadea I, Bouza E; MYCOMED Zygomycosis Study Group (2007) Impact of zygomycosis on microbiology workload: a survey study in Spain. J Clin Microbiol 45:2051–2053CrossRefPubMedPubMedCentral
39.
go back to reference Bitar D, Van Cauteren D, Lanternier F, Dannaoui E, Che D, Dromer F, Desenclos J-C, Lortholary O (2009) Increasing incidence of zygomycosis (mucormycosis), France, 1997–2006. Emerg Infect Dis 15:1395–1401CrossRefPubMedPubMedCentral Bitar D, Van Cauteren D, Lanternier F, Dannaoui E, Che D, Dromer F, Desenclos J-C, Lortholary O (2009) Increasing incidence of zygomycosis (mucormycosis), France, 1997–2006. Emerg Infect Dis 15:1395–1401CrossRefPubMedPubMedCentral
40.
go back to reference Diabetes: factos e números 2014. Relatório anual do observatório nacional da diabetes. Direção Geral de Saúde, 11/2014. Accessed 25 June 2016 Diabetes: factos e números 2014. Relatório anual do observatório nacional da diabetes. Direção Geral de Saúde, 11/2014. Accessed 25 June 2016
41.
go back to reference Gascón J, Torres JM, Jiménez M, Mejias T, Triviño L, Gobbi F, Quintó L, Puig J, Corachan M (2005) Histoplasmosis infection in Spanish travelers to Latin America. Eur J Clin Microbiol Infect Dis 24:839–841CrossRefPubMed Gascón J, Torres JM, Jiménez M, Mejias T, Triviño L, Gobbi F, Quintó L, Puig J, Corachan M (2005) Histoplasmosis infection in Spanish travelers to Latin America. Eur J Clin Microbiol Infect Dis 24:839–841CrossRefPubMed
42.
go back to reference Lopes MJ, Batista J, Trigo D, Cunha J, Pacheco P (2015) Histoplasmose africana: Apresentação atípica 40 anos após exposição. 14° Encontro Nacional de Atualização em infeciologia. 4–16 Outubro 2015, Porto, Portugal Lopes MJ, Batista J, Trigo D, Cunha J, Pacheco P (2015) Histoplasmose africana: Apresentação atípica 40 anos após exposição. 14° Encontro Nacional de Atualização em infeciologia. 4–16 Outubro 2015, Porto, Portugal
Metadata
Title
Serious fungal infections in Portugal
Authors
R. Sabino
C. Verissímo
J. Brandão
C. Martins
D. Alves
C. Pais
D. W. Denning
Publication date
01-07-2017
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 7/2017
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-017-2930-y

Other articles of this Issue 7/2017

European Journal of Clinical Microbiology & Infectious Diseases 7/2017 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.